Twist Bioscience Corporation (TWST) financial statements and ratios from SEC XBRL: revenue $376.57M (TTM), net margin -20.6%, revenue growth 23.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $376.57M |
| Net Margin | -20.6% |
| Return on Equity | -30.7% |
| Current Ratio | 2.67 |
| Revenue Growth (YoY) | 23.2% |
| EPS Growth (YoY) | -264.7% |
| FCF Growth (YoY) | -18.1% |
| Price / Book | 19.04 |
| Price / Sales | 19.66 |
| FCF Yield | -1.1% |
| Altman Z-Score | 27.07 (safe) |
| Sector P/E (Healthcare) | 21.6 |
TWST overview · TWST earnings · TWST KPIs · TWST investor relations · TWST ownership · TWST peers · TWST filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.